RxDoctor Payments Data

Jalal Itani, MD

Diagnostic Radiology · Oklahoma City, OKNPI 1770080251

Payments from drug & device makers

$134in general payments, 2019–2025

Across 9 payments — averaging $14.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$35
  • AstraZeneca$27
  • Pfizer$27
  • Angiodynamics, Inc.$16
  • Amgen$16
  • Johnson & Johnson$13

What the payments were for

  • Food & beverage$134100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck2$35
AstraZeneca2$27
Pfizer2$27
Angiodynamics, Inc.1$16
Amgen1$16
Johnson & Johnson1$13

How this compares

$134 in reported general payments places this provider in the 70th percentile of 296 diagnostic radiology providers in Oklahoma.

See all diagnostic radiology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$109,329
Medicare patients
1,749
Services billed
2,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →